Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options 
TRxADE HEALTH to Present at Upcoming Investor Conferences in September
TAMPA, FL / ACCESSWIRE / September 7, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on...
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's...
Rendever Unveils RendeverFit™ – A New Virtual Reality Fitness Platform for Seniors
The pioneering platform will premiere at Argentum Senior Living Executive Conference & ExpoBOSTON, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Rendever,...
Adial Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
CHARLOTTESVILLE, Va., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage...
INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated...
Panbela to Present at Upcoming Investor Conferences
MINNEAPOLIS, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
DURHAM, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula...
Capricor Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
-Conference Dates: September 13–15, 2021-LOS ANGELES, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused...
HMNC Brain Health to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
MUNICH, Germany, Sept. 07, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company...
Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy
CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
PDS Biotechnology to Present at the HC Wainwright 23rd Annual Global Investment Conference
FLORHAM PARK, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Daxor Corporation to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Oak Ridge, TN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology,...
Bellerophon to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
WARREN, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics
Industry-changing partnership will increase patient access to NeuroStar® Advanced Therapy for Mental HealthMALVERN, Pa. and ST. GEORGE, Utah, Sept. 07,...
CorMedix Inc. Announces Regulatory Update
BERKELEY HEIGHTS, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program
CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,...
Wave Life Sciences to Highlight RNA Editing Modality and PRISM Platform Advancements During Upcoming Scientific Conferences
Nine presentations and posters at TIDES USA and OTSCAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd....
Albireo Sells Priority Review Voucher (PRV) for $105 Million
– PRV was granted to Albireo with the FDA approval of BylvayTM (odevixibat) in July – – Non-dilutive capital further...
Skye Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
SAN DIEGO, CA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary,...
Metacrine to Present at H.C. Wainwright 23rd Annual Global Investment Conference
SAN DIEGO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients...